{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T07:53:33Z","timestamp":1791359613587,"version":"4.3.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T00:00:00Z","timestamp":1787529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T00:00:00Z","timestamp":1787529600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s11060-026-05749-3","type":"journal-article","created":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T10:42:31Z","timestamp":1787568151000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Molecular features of intratumoral hemorrhage in glioblastoma isocitrate dehydrogenase-wildtype"],"prefix":"10.1007","volume":"179","author":[{"given":"Angel","family":"Bueno","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Dono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oscar","family":"Alcantar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Amezquita-Contreras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Ocasio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sigmund","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Amsbaugh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay-Jiguang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angel I.","family":"Blanco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roy F.","family":"Riascos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leomar Y.","family":"Ballester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nitin","family":"Tandon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9757-1453","authenticated-orcid":false,"given":"Yoshua","family":"Esquenazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,24]]},"reference":[{"key":"5749_CR1","doi-asserted-by":"publisher","first-page":"v1","DOI":"10.1093\/neuonc\/noac202","volume":"24","author":"QT Ostrom","year":"2022","unstructured":"Ostrom QT, Price M, Neff C et al (2022) CBTRUS statistical report: Primary brain and other central nervous system tumors diagnosed in the United States in 2015\u20132019. Neuro Oncol 24:v1\u2013v95. https:\/\/doi.org\/10.1093\/neuonc\/noac202","journal-title":"Neuro Oncol"},{"key":"5749_CR2","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1007\/s11060-025-05356-8","volume":"176","author":"JT Fortunato","year":"2026","unstructured":"Fortunato JT, Scharf A, Shuman AG, Diamond EL (2026) Staging prognostic discussions about glioblastoma. J Neurooncol 176:162. https:\/\/doi.org\/10.1007\/s11060-025-05356-8","journal-title":"J Neurooncol"},{"key":"5749_CR3","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJMoa043330","volume":"352","author":"R Stupp","year":"2005","unstructured":"Stupp R, Mason WP, van den Bent MJ et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987\u2013996. https:\/\/doi.org\/10.1056\/NEJMoa043330","journal-title":"N Engl J Med"},{"key":"5749_CR4","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1007\/s11060-025-05143-5","volume":"175","author":"J Torres","year":"2025","unstructured":"Torres J, Bundrant BE, Dono A et al (2025) Cystic glioblastoma IDH-wildtype: genetic alterations and outcomes. J Neurooncol 175:515\u2013523. https:\/\/doi.org\/10.1007\/s11060-025-05143-5","journal-title":"J Neurooncol"},{"key":"5749_CR5","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","volume":"23","author":"DN Louis","year":"2021","unstructured":"Louis DN, Perry A, Wesseling P et al (2021) The 2021 WHO classification of tumors of the Central Nervous System: A summary. Neuro Oncol 23:1231\u20131251. https:\/\/doi.org\/10.1093\/neuonc\/noab106","journal-title":"Neuro Oncol"},{"key":"5749_CR6","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1186\/s12883-024-03703-2","volume":"24","author":"Y Shi","year":"2024","unstructured":"Shi Y, Kang X, Ge Y et al (2024) The molecular signature and prognosis of glioma with preoperative intratumoral hemorrhage: a retrospective cohort analysis. BMC Neurol 24:202. https:\/\/doi.org\/10.1186\/s12883-024-03703-2","journal-title":"BMC Neurol"},{"key":"5749_CR7","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1007\/s007010070052","volume":"142","author":"B Schrader","year":"2000","unstructured":"Schrader B, Barth H, Lang EW et al (2000) Spontaneous intracranial haematomas caused by neoplasms. Acta Neurochir (Wien) 142:979\u2013985. https:\/\/doi.org\/10.1007\/s007010070052","journal-title":"Acta Neurochir (Wien)"},{"key":"5749_CR8","doi-asserted-by":"publisher","first-page":"852","DOI":"10.3171\/jns.1987.67.6.0852","volume":"67","author":"D Kondziolka","year":"1987","unstructured":"Kondziolka D, Bernstein M, Resch L et al (1987) Significance of hemorrhage into brain tumors: clinicopathological study. J Neurosurg 67:852\u2013857. https:\/\/doi.org\/10.3171\/jns.1987.67.6.0852","journal-title":"J Neurosurg"},{"key":"5749_CR9","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1186\/s40478-025-02114-9","volume":"13","author":"Y Wu","year":"2025","unstructured":"Wu Y, Wu Y, Xia S et al (2025) JMJD6-driven epigenetic activation of COL4A2 reprograms glioblastoma vascularization via integrin \u03b11\u03b21-dependent PI3K\/MAPK signaling. Acta Neuropathol Commun 13:194. https:\/\/doi.org\/10.1186\/s40478-025-02114-9","journal-title":"Acta Neuropathol Commun"},{"key":"5749_CR10","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1093\/neuonc\/nox175","volume":"20","author":"JN Sarkaria","year":"2018","unstructured":"Sarkaria JN, Hu LS, Parney IF et al (2018) Is the blood-brain barrier really disrupted in all glioblastomas? A critical assessment of existing clinical data. Neuro Oncol 20:184\u2013191. https:\/\/doi.org\/10.1093\/neuonc\/nox175","journal-title":"Neuro Oncol"},{"key":"5749_CR11","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s11060-016-2350-3","volume":"132","author":"BG McGahan","year":"2017","unstructured":"McGahan BG, Neilsen BK, Kelly DL et al (2017) Assessment of vascularity in glioblastoma and its implications on patient outcomes. J Neurooncol 132:35\u201344. https:\/\/doi.org\/10.1007\/s11060-016-2350-3","journal-title":"J Neurooncol"},{"key":"5749_CR12","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1148\/radiol.13120118","volume":"267","author":"DA Gutman","year":"2013","unstructured":"Gutman DA, Cooper LAD, Hwang SN et al (2013) MR imaging predictors of molecular profile and survival: multi-institutional study of the TCGA glioblastoma data set. Radiology 267:560\u2013569. https:\/\/doi.org\/10.1148\/radiol.13120118","journal-title":"Radiology"},{"key":"5749_CR13","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s40644-023-00638-8","volume":"24","author":"NH Setyawan","year":"2024","unstructured":"Setyawan NH, Choridah L, Nugroho HA et al (2024) Beyond invasive biopsies: using VASARI MRI features to predict grade and molecular parameters in gliomas. Cancer Imaging 24:3. https:\/\/doi.org\/10.1186\/s40644-023-00638-8","journal-title":"Cancer Imaging"},{"key":"5749_CR14","unstructured":"VASARI research project https:\/\/wiki.cancerimagingarchive.net\/display\/Public\/VASARI+Research+Project. Accessed 26 Feb 2026"},{"key":"5749_CR15","doi-asserted-by":"publisher","first-page":"103871","DOI":"10.1016\/j.jbi.2021.103871","volume":"121","author":"AC Cheng","year":"2021","unstructured":"Cheng AC, Duda SN, Taylor R et al (2021) REDCap on FHIR: Clinical Data Interoperability Services. J Biomed Inf 121:103871. https:\/\/doi.org\/10.1016\/j.jbi.2021.103871","journal-title":"J Biomed Inf"},{"key":"5749_CR16","doi-asserted-by":"publisher","unstructured":"Bueno A, Dono A, Amezquita-Contreras C et al (2026) Molecular features of glioblastoma isocitrate dehydrogenase-wildtype in extreme survival groups after supramaximal and maximal resection. Neurosurgery. https:\/\/doi.org\/10.1227\/neu.0000000000003929.","DOI":"10.1227\/neu.0000000000003929"},{"key":"5749_CR17","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1111\/bioe.12581","volume":"33","author":"A Ballantyne","year":"2019","unstructured":"Ballantyne A, Eriksson S (2019) Research ethics revised: The new CIOMS guidelines and the World Medical Association Declaration of Helsinki in context. Bioethics 33:310\u2013311. https:\/\/doi.org\/10.1111\/bioe.12581","journal-title":"Bioethics"},{"key":"5749_CR18","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","volume":"370","author":"E von Elm","year":"2007","unstructured":"von Elm E, Altman DG, Egger M et al (2007) The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet 370:1453\u20131457. https:\/\/doi.org\/10.1016\/S0140-6736(07)61602-X","journal-title":"Lancet"},{"key":"5749_CR19","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1093\/neuonc\/noac193","volume":"25","author":"P Karschnia","year":"2023","unstructured":"Karschnia P, Young JS, Dono A et al (2023) Prognostic validation of a new classification system for extent of resection in glioblastoma: A report of the RANO resect group. Neuro Oncol 25:940\u2013954. https:\/\/doi.org\/10.1093\/neuonc\/noac193","journal-title":"Neuro Oncol"},{"key":"5749_CR20","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s11060-020-03539-z","volume":"148","author":"A Dono","year":"2020","unstructured":"Dono A, Wang E, Lopez-Rivera V et al (2020) Molecular characteristics and clinical features of multifocal glioblastoma. J Neurooncol 148:389\u2013397. https:\/\/doi.org\/10.1007\/s11060-020-03539-z","journal-title":"J Neurooncol"},{"key":"5749_CR21","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s11060-020-03689-0","volume":"152","author":"A Dono","year":"2021","unstructured":"Dono A, Amsbaugh M, Martir M et al (2021) Genomic alterations predictive of response to radiosurgery in recurrent IDH-WT glioblastoma. J Neurooncol 152:153\u2013162. https:\/\/doi.org\/10.1007\/s11060-020-03689-0","journal-title":"J Neurooncol"},{"key":"5749_CR22","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1158\/1055-9965.EPI-14-0275","volume":"23","author":"JP Thakkar","year":"2014","unstructured":"Thakkar JP, Dolecek TA, Horbinski C et al (2014) Epidemiologic and molecular prognostic review of glioblastoma. Cancer Epidemiol Biomarkers Prev 23:1985\u20131996. https:\/\/doi.org\/10.1158\/1055-9965.EPI-14-0275","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"5749_CR23","unstructured":"cBioPortal for cancer genomics::oncoprinter. https:\/\/www.cbioportal.org\/oncoprinter. Accessed 21 Feb 2025"},{"key":"5749_CR24","doi-asserted-by":"publisher","first-page":"2258","DOI":"10.11406\/rinketsu.56.2258","volume":"56","author":"Y Kanda","year":"2015","unstructured":"Kanda Y (2015) [Statistical analysis using freely-available EZR (Easy R) software]. Rinsho Ketsueki 56:2258\u20132266. https:\/\/doi.org\/10.11406\/rinketsu.56.2258","journal-title":"Rinsho Ketsueki"},{"key":"5749_CR25","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s007010050019","volume":"142","author":"DG Kim","year":"2000","unstructured":"Kim DG, Park CK, Paek SH et al (2000) Meningioma manifesting intracerebral haemorrhage: a possible mechanism of haemorrhage. Acta Neurochir (Wien) 142:165\u2013168. https:\/\/doi.org\/10.1007\/s007010050019","journal-title":"Acta Neurochir (Wien)"},{"key":"5749_CR26","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s11060-024-04575-9","volume":"167","author":"A Dono","year":"2024","unstructured":"Dono A, Torres J, Nunez L et al (2024) Imaging predictors of 4q12 amplified and RB1 mutated glioblastoma IDH-wildtype. J Neurooncol 167:99\u2013109. https:\/\/doi.org\/10.1007\/s11060-024-04575-9","journal-title":"J Neurooncol"},{"key":"5749_CR27","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/s12017-023-08749-y","volume":"25","author":"BS Carlotto","year":"2023","unstructured":"Carlotto BS, Trevisan P, Provenzi VO et al (2023) PDGFRA, KIT, and KDR gene amplification in glioblastoma: Heterogeneity and clinical significance. Neuromolecular Med 25:441\u2013450. https:\/\/doi.org\/10.1007\/s12017-023-08749-y","journal-title":"Neuromolecular Med"},{"key":"5749_CR28","doi-asserted-by":"publisher","first-page":"vdab050","DOI":"10.1093\/noajnl\/vdab050","volume":"3","author":"A Dono","year":"2021","unstructured":"Dono A, Ramesh AV, Wang E et al (2021) The role of RB1 alteration and 4q12 amplification in IDH-WT glioblastoma. Neurooncol Adv 3:vdab050. https:\/\/doi.org\/10.1093\/noajnl\/vdab050","journal-title":"Neurooncol Adv"},{"key":"5749_CR29","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1002\/path.1823","volume":"207","author":"H Joensuu","year":"2005","unstructured":"Joensuu H, Puputti M, Sihto H et al (2005) Amplification of genes encoding KIT, PDGFRalpha and VEGFR2 receptor tyrosine kinases is frequent in glioblastoma multiforme. J Pathol 207:224\u2013231. https:\/\/doi.org\/10.1002\/path.1823","journal-title":"J Pathol"},{"key":"5749_CR30","doi-asserted-by":"publisher","first-page":"3499","DOI":"10.1523\/JNEUROSCI.5049-04.2005","volume":"25","author":"RD McKinnon","year":"2005","unstructured":"McKinnon RD, Waldron S, Kiel ME (2005) PDGF alpha-receptor signal strength controls an RTK rheostat that integrates phosphoinositol 3\u2019-kinase and phospholipase Cgamma pathways during oligodendrocyte maturation. J Neurosci 25:3499\u20133508. https:\/\/doi.org\/10.1523\/JNEUROSCI.5049-04.2005","journal-title":"J Neurosci"},{"key":"5749_CR31","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1111\/j.1440-1789.2011.01204.x","volume":"31","author":"S Nobusawa","year":"2011","unstructured":"Nobusawa S, Stawski R, Kim Y-H et al (2011) Amplification of the PDGFRA, KIT and KDR genes in glioblastoma: a population-based study: PDGFRA amplification in glioblastoma. Neuropathology 31:583\u2013588. https:\/\/doi.org\/10.1111\/j.1440-1789.2011.01204.x","journal-title":"Neuropathology"},{"key":"5749_CR32","first-page":"3213","volume":"52","author":"M Hermanson","year":"1992","unstructured":"Hermanson M, Funa K, Hartman M et al (1992) Platelet-derived growth factor and its receptors in human glioma tissue: expression of messenger RNA and protein suggests the presence of autocrine and paracrine loops. Cancer Res 52:3213\u20133219","journal-title":"Cancer Res"},{"key":"5749_CR33","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1038\/nature07385","volume":"455","author":"Cancer Genome Atlas Research Network","year":"2008","unstructured":"Cancer Genome Atlas Research Network (2008) Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 455:1061\u20131068. https:\/\/doi.org\/10.1038\/nature07385","journal-title":"Nature"},{"key":"5749_CR34","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1002\/jnr.490360512","volume":"36","author":"JA Ida Jr","year":"1993","unstructured":"Ida JA Jr, Dubois-Dalcq M, McKinnon RD (1993) Expression of the receptor tyrosine kinase c-kit in oligodendrocyte progenitor cells. J Neurosci Res 36:596\u2013606. https:\/\/doi.org\/10.1002\/jnr.490360512","journal-title":"J Neurosci Res"},{"key":"5749_CR35","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1677\/erc.0.0080161","volume":"8","author":"E Zwick","year":"2001","unstructured":"Zwick E, Bange J, Ullrich A (2001) Receptor tyrosine kinase signalling as a target for cancer intervention strategies. Endocr Relat Cancer 8:161\u2013173. https:\/\/doi.org\/10.1677\/erc.0.0080161","journal-title":"Endocr Relat Cancer"},{"key":"5749_CR36","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1038\/nrc2664","volume":"9","author":"JA Engelman","year":"2009","unstructured":"Engelman JA (2009) Targeting PI3K signalling in cancer: opportunities, challenges and limitations. Nat Rev Cancer 9:550\u2013562. https:\/\/doi.org\/10.1038\/nrc2664","journal-title":"Nat Rev Cancer"},{"key":"5749_CR37","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1016\/S0002-9440(10)63905-3","volume":"162","author":"P Guo","year":"2003","unstructured":"Guo P, Hu B, Gu W et al (2003) Platelet-derived growth factor-B enhances glioma angiogenesis by stimulating vascular endothelial growth factor expression in tumor endothelia and by promoting pericyte recruitment. Am J Pathol 162:1083\u20131093. https:\/\/doi.org\/10.1016\/S0002-9440(10)63905-3","journal-title":"Am J Pathol"},{"key":"5749_CR38","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/labinvest.3700070","volume":"84","author":"DJ Brat","year":"2004","unstructured":"Brat DJ, Van Meir EG (2004) Vaso-occlusive and prothrombotic mechanisms associated with tumor hypoxia, necrosis, and accelerated growth in glioblastoma. Lab Invest 84:397\u2013405. https:\/\/doi.org\/10.1038\/labinvest.3700070","journal-title":"Lab Invest"},{"key":"5749_CR39","first-page":"236","volume":"63","author":"N Pore","year":"2003","unstructured":"Pore N, Liu S, Haas-Kogan DA et al (2003) PTEN mutation and epidermal growth factor receptor activation regulate vascular endothelial growth factor (VEGF) mRNA expression in human glioblastoma cells by transactivating the proximal VEGF promoter. Cancer Res 63:236\u2013241","journal-title":"Cancer Res"},{"key":"5749_CR40","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.3390\/biomedicines10061285","volume":"10","author":"A Mosteiro","year":"2022","unstructured":"Mosteiro A, Pedrosa L, Ferr\u00e9s A et al (2022) The vascular microenvironment in glioblastoma: A comprehensive review. Biomedicines 10:1285. https:\/\/doi.org\/10.3390\/biomedicines10061285","journal-title":"Biomedicines"},{"key":"5749_CR41","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1007\/s00439-025-02740-2","volume":"144","author":"B Chen","year":"2025","unstructured":"Chen B, Zhang C, Rui H et al (2025) Histone H3K36 methyltransferases NSD1 and SETD2 are required for brain development. Hum Genet 144:529\u2013543. https:\/\/doi.org\/10.1007\/s00439-025-02740-2","journal-title":"Hum Genet"},{"key":"5749_CR42","doi-asserted-by":"publisher","first-page":"7558","DOI":"10.4081\/ni.2018.7558","volume":"10","author":"SA Richard","year":"2018","unstructured":"Richard SA, Ye Y, Li H et al (2018) Glioblastoma multiforme subterfuge as acute cerebral hemorrhage: A case report and literature review. Neurol Int 10:7558. https:\/\/doi.org\/10.4081\/ni.2018.7558","journal-title":"Neurol Int"},{"key":"5749_CR43","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1016\/j.jocn.2012.09.041","volume":"20","author":"L Li","year":"2013","unstructured":"Li L, Yin J, Li Y et al (2013) Anaplastic astrocytoma masquerading as hemorrhagic stroke. J Clin Neurosci 20:1612\u20131614. https:\/\/doi.org\/10.1016\/j.jocn.2012.09.041","journal-title":"J Clin Neurosci"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-026-05749-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11060-026-05749-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-026-05749-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T07:34:48Z","timestamp":1791358488000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11060-026-05749-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,24]]},"references-count":43,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["5749"],"URL":"https:\/\/doi.org\/10.1007\/s11060-026-05749-3","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,24]]},"assertion":[{"value":"13 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the institutional review board of The University of Texas Health Science Center at Houston and Memorial Hermann Hospital, Houston, TX (HSC-MS-17-1917), and it was in accordance with the 1964 Helsinki Declaration and its later amendments. This study also adheres to the STROBE guidelines.","order":1,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent to participate and publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"51"}}